Longevity Health Holdings, Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending September 30, 2025. The company achieved net sales of $425,864 for the third quarter, a substantial increase of 1,975% compared to $20,519 in the same period last year. For the nine months ended September 30, 2025, net sales reached $1,439,829, up 4,285% from $32,839 in the prior year. Despite this growth, the company reported a net loss of $1,429,755 for the quarter, a 50% improvement from a loss of $2,878,481 in the third quarter of 2024. The nine-month net loss also decreased to $4,822,060 from $9,453,978 year-over-year.
The financial performance reflects the impact of the Elevai Acquisition, completed in January 2025, which contributed to the surge in sales. The acquisition included skincare and haircare products that have been integrated into Longevity's offerings. The company reported gross profit of $254,463 for the third quarter, compared to $15,679 in the previous year, indicating improved margins despite increased operating expenses. Total operating expenses rose to $1,725,480 from $1,435,468, driven primarily by heightened selling and marketing efforts associated with the new product lines.
Operationally, Longevity Health Holdings has seen a notable increase in its customer base and product engagement metrics. The company reported a significant rise in inventory, totaling $1,013,368 as of September 30, 2025, compared to $108,705 at the end of 2024, reflecting its strategy to support increased sales volume. The company’s cash position improved to $1,109,228 from $157,139 at the end of 2024, bolstered by financing activities that included proceeds from the exercise of common stock warrants and an at-the-market equity offering.
Looking ahead, Longevity Health Holdings faces challenges related to its liquidity and ongoing operational costs. The company reported negative working capital of $3,997,047 and negative cash flow from operations of $3,022,899 for the nine months ended September 30, 2025. Management has indicated that additional capital will be necessary to sustain operations, particularly as it navigates the complexities of the pending THPlasma merger and seeks to expand its product offerings. The company is actively exploring options for raising further equity or debt financing to support its growth strategy and operational needs.
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc. develops bio-aesthetic and regenerative products, including skincare, haircare, and tissue healing solutions. Its core offerings leverage proprietary biologics, exosomes, and platelet-rich plasma to promote skin rejuvenation, hair growth, and tissue repair. Serving medical and consumer markets, the company emphasizes safety, innovation, and scientific validation, with a focus on professional channels and direct-to-consumer sales in the growing aesthetic industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.